Literature DB >> 28315657

Magnitude and determinants of adverse treatment outcomes among tuberculosis patients registered under Revised National Tuberculosis Control Program in a Tuberculosis Unit, Wardha, Central India: A record-based cohort study.

Anuj Mundra1, Pradeep R Deshmukh2, Ajay Dawale3.   

Abstract

INTRODUCTION: Deaths, defaults, relapses, and treatment failures have made the control of TB difficult across the globe.
METHODOLOGY: This study is a record-based follow-up of a cohort of patients registered under Revised National Tuberculosis Control Program in the year 2014 in Wardha Tuberculosis Unit, India. Data was collected from the records available at the District Tuberculosis Office.
RESULTS: Data of 510 patients was analyzed. The sputum conversion rate was 88%. The overall treatment success rate was 81.9%, and rates of any adverse outcome, deaths, defaults, failure, and shift to Category IV regimen were 32.60/100 person years at risk (PYAR), 16.88/100 PYAR, 11.12/100 PYAR, 3.45/100 PYAR, and 1.15/100 PYAR, respectively. The median times for the above outcomes were 81days, 110days, 66days, 118days, and 237days, respectively. The cumulative probability of occurrence at 6months of any adverse outcome, deaths, default, failure, and shift to Category IV regimen was 0.145, 0.056, 0.088, 0.002, and 0.004, respectively. On multivariate analysis, the determinant of any adverse outcome was age >45years, whereas extrapulmonary disease was protective. The hazard of defaulting was also significantly higher in male patients and those aged >45years.
CONCLUSION: Appropriate interventions and program implementation to reduce the adverse treatment outcomes and interruptions will help in improving program performance.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  DOTS; Survival probability; Treatment adherence; Treatment outcomes

Mesh:

Substances:

Year:  2017        PMID: 28315657     DOI: 10.1016/j.jegh.2017.02.002

Source DB:  PubMed          Journal:  J Epidemiol Glob Health        ISSN: 2210-6006


  5 in total

1.  "Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.

Authors:  Anwita Khaitan; Sanjay K Rai; Anand Krishnan; Sanjeev K Gupta; Shashi Kant; Gopi C Khilnani
Journal:  Cureus       Date:  2022-05-15

2.  Diabetes among tuberculosis patients and its impact on tuberculosis treatment in South Asia: a systematic review and meta-analysis.

Authors:  Sanju Gautam; Nipun Shrestha; Sweta Mahato; Tuan P A Nguyen; Shiva Raj Mishra; Gabriele Berg-Beckhoff
Journal:  Sci Rep       Date:  2021-01-22       Impact factor: 4.379

3.  Medication Event Monitoring System for Infectious Tuberculosis Treatment in Morocco: A Retrospective Cohort Study.

Authors:  Seup Park; Ilham Sentissi; Seung Jae Gil; Won-Seok Park; ByungKwon Oh; Ah Reum Son; Young Ju Kong; Sol Park; Eunseong Paek; Yong Joon Park; Seung Heon Lee
Journal:  Int J Environ Res Public Health       Date:  2019-01-31       Impact factor: 3.390

4.  Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis.

Authors:  Ninfa Marlen Chaves Torres; Jecxy Julieth Quijano Rodríguez; Pablo Sebastián Porras Andrade; María Belen Arriaga; Eduardo Martins Netto
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

5.  Reasons for loss to follow-up (LTFU) of pulmonary TB (PTB) patients: A qualitative study among Saharia, a particularly vulnerable tribal group of Madhya Pradesh, India.

Authors:  Prashant Mishra; Ravendra K Sharma; Rajiv Yadav; V G Rao; Samridhi Nigam; Mercy Aparna Lingala; Jyothi Bhat
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.